Closures for Pharmaceutical Preparations: A Review of Design and Test Considerations - The author examines the use of closures for products intended for injection. - BioPharm International

ADVERTISEMENT

Closures for Pharmaceutical Preparations: A Review of Design and Test Considerations
The author examines the use of closures for products intended for injection.


BioPharm International
Volume 25, Issue 12, pp. 32-36

Packaging

After packaging, a selection of bags should be examined for tears as a part of the quality control assessment. The placement of the stoppers into the packaging should be undertaken within an ISO Class 8/EU GMP Grade C cleanroom for standard stoppers and in an ISO Class 5/EU GMP Grade A environment for ready-to-sterilize or ready-to-use stoppers.

Sterilization

Closures are typically sterilized by one of two methods: steam sterilization using autoclaves and gamma irradiation. It should be noted that not all types of stoppers can be sterilized by gamma irradiation because the rubber of the stopper will become brittle from the generation of free radicals in the polymeric materials (11).

The sterilization of stoppers also requires the sterilization device to be subject to the standard tests including thermometric studies and biological indicators for steam sterilization devices and dosimeters for gamma irradiation.

CONCLUSION

The container-closure system is an essential part of the final presentation of a pharmaceutical product. It defines the closure, protection, and functionality of a container while ensuring the safety and quality of the drug product over the product shelf life. This article has addressed the important considerations for closures: the "rubber" stoppers inserted into vials of products and sealed in place. The article has focused upon the important tests, control measures, and essential aspects for ensuring that the product, in its final packaging, is fit-for-purpose prior to the administration of the drug.

Tim Sandle, PhD, Bio Products Laboratory, Dagger Lane, Elstree, WD6 3BX, United Kingdom,
.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

New Tax Rules May Deter Future Pharma M&A
October 1, 2014
NIH Seeks to Improve Vaccine Response with New Adjuvants
September 30, 2014
New Report Details Players and Pipelines in the Biosimilar Space
September 30, 2014
Baxter International Plans to Open R&D Center for Baxalta
September 30, 2014
FDA Releases First-Ever Purple Book for Biosimilar Characterization
September 26, 2014
Author Guidelines
Source: BioPharm International,
Click here